Harvard Bioscience (HBIO) Free Cash Flow Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 30.99% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 414.89% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 43.37% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 27.06% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -4.85% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -37.77% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 23.97% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -3.97% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -38.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.99% |
| Dec 31, 2025 | -30.51% |
| Sep 30, 2025 | 61.81% |
| Jun 30, 2025 | 83.89% |
| Mar 31, 2025 | 44.33% |
| Dec 31, 2024 | 99.24% |
| Sep 30, 2024 | -14.74% |
| Jun 30, 2024 | -70.55% |
| Mar 31, 2024 | -5.07% |
| Dec 31, 2023 | 12.70% |
| Sep 30, 2023 | 58.89% |
| Jun 30, 2023 | 13.24% |
| Mar 31, 2023 | -15.48% |
| Dec 31, 2022 | 11.10% |
| Sep 30, 2022 | -58.05% |
| Jun 30, 2022 | -54.34% |
| Mar 31, 2022 | -49.12% |
| Dec 31, 2021 | -27.99% |
| Sep 30, 2021 | 12.32% |
| Jun 30, 2021 | -20.91% |